NCT00003534 2018-01-31
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Withdrawn
Burzynski Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)